Back to search

Article

Serum biomarker CD163 predicts overall survival in patients with pancreatic ductal adenocarcinoma

2019-07-25

Abstract excerpt

<title>Abstract</title> <p>Background The serum soluble CD163 (sCD163) is elevated in patients with infection disease and several types of cancer. However, the prognostic value of serum sCD163 in pancreatic ductal adenocarcinoma (PDAC) has not yet been investigated. Methods Serum level of sCD163 was measured by using the peripheral blood of 54 patients with PDAC, 20 patients with benign tumor of pancreas, and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
45785d69-5b7d-5647-918e-cb11de2decb2
DOI
10.21203/rs.2.11901/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Serum biomarker CD163 predicts overall survival in patients with pancreatic ductal adenocarcinomaDOI 10.21203/rs.2.11901/v1
Prognostic value of CD163+ macrophages in solid tumor malignancies: A scoping reviewSemantic proximity
Toripalimab combined with albumin-paclitaxel plus gemcitabine as first-line treatment for locally advanced or metastatic pancreatic ductal adenocarcinoma: an open-label, phase Ib/II study and investigation of potential biomarkersSemantic proximity
Comparative Immune profiling in Pancreatic Ductal Adenocarcinoma Progression Among South African patientsSemantic proximity
Neutrophil-lymphocyte ratio (NLR) was associated with prognosis and immunomodulatory in patients with pancreatic ductal adenocarcinoma (PDAC).Semantic proximity
Pancreatic cancer cells elevated MARCO expression on tumor-associated macrophages and promote the development of pancreatic ductal adenocarcinoma via inhibiting adaptive immune responseSemantic proximity
Topographical Distribution and Spatial Interactions of Innate and Semi-Innate Immune Cells in Pancreatic and Other Periampullary Adenocarcinoma.Semantic proximity
Prognostic value and predictive biomarkers of tumor-associated macrophages and cancer stem cells cooperatively in colorectal cancerSemantic proximity
Optimal value of CA19-9 determined by KRAS-mutated circulating tumor DNA contributes to the prediction of prognosis in pancreatic cancer patients.Semantic proximity
Impact of Jaundice-Induced Elevated Red Blood Cell Distribution Width on Survival Outcomes in Pancreatic Cancer Patients: A Retrospective Cohort StudySemantic proximity
Robust circulating microRNA signature for the diagnosis and early detection of pancreatobiliary cancerSemantic proximity
The M2 phenotype of tumor-associated macrophages in the stroma confers a poor prognosis in pancreatic cancer.Semantic proximity
Prospective markers for early diagnosis and prognosis of sporadic pancreatic ductal adenocarcinoma.Semantic proximity
Select a neighboring publication to make it the new centre.